Brief: FDA Grants Fast Track Designation For Merck KGaA's Cladribine Capsules For The Treatment Of gMG
24/11/2025 13:02
Nov 24 (Reuters) - MERCK KGAA MRCG.DE: FDA HAS GRANTED FAST TRACK DESIGNATION FOR CLADRIBINE CAPSULES FOR THE TREATMENT OF GMG Further company coverage: MRCG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Merck KGaA
See all newsUS stocks weekly: AI reality
US stocks weekly: AI reality
Brief: Bio-Techne Co Will Be Required To Pay To Merck KGaA Termination Fee Equal To $230.5 Million If Deal Terminated Under Certain Circumstances - SEC Filing
Press Digest: Financial Times - June 26
US STOCKS-Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook